JBM (Healthcare) Limited (HKG:2161)
Hong Kong · Delayed Price · Currency is HKD 1.625
+0.030 (1.88%)
Oct 9, 2026, 4:08 PM HKT
JBM (Healthcare) Revenue
In the fiscal year ending March 31, 2026, JBM (Healthcare) had annual revenue of 834.63M HKD with 6.69% growth. JBM (Healthcare) had revenue of 404.99M in the half year ending March 31, 2026, with 25.93% growth. That makes JBM (Healthcare) the 22,159th largest company in the world by revenue and 1,302nd in Hong Kong.
Revenue
834.63M
Revenue Growth
+6.69%
P/S Ratio
1.60
Revenue / Employee
2.07M
Employees
404
Market Cap
1.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 834.63M | 52.34M | 6.69% |
| Mar 31, 2025 | 782.29M | 133.88M | 20.65% |
| Mar 31, 2024 | 648.42M | 128.09M | 24.62% |
| Mar 31, 2023 | 520.32M | 114.18M | 28.11% |
| Mar 31, 2022 | 406.14M | 8.98M | 2.26% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CPBIO Holding Company | 3.32B |
| Essex Bio-Technology | 1.72B |
| Jacobson Pharma Corporation | 1.57B |
| Dawnrays Pharmaceutical (Holdings) | 1.32B |
| Golden Throat Holdings Group Company | 1.04B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.04B |
| Hua Medicine (Shanghai) | 755.49M |
| CF PharmTech | 504.27M |